Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S B Mekapati

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Bioorganic & Medicinal Chemistry|October 13, 2001
Comparative QSAR studies on bibenzimidazoles and terbenzimidazoles inhibiting topoisomerase IS B Mekapati, C Hansch
Bioorganic & Medicinal Chemistry|November 17, 2001
QSAR of the inhibition of angiogenesis by TNP-470 and ovalicin analogues: another example of an allosteric interactionS B Mekapati, C Hansch
Journal of Enzyme Inhibition|November 8, 2001
Quantitative structure-activity relationship of some HIV-1 protease inhibitors: a Fujita-Ban type analysisS B Mekapati, R Sivakumar, S P Gupta
Current Topics in Medicinal Chemistry|December 10, 2002
QSAR: then and nowC D Selassie, S B Mekapati, R P Verma
Bioorganic & Medicinal Chemistry|October 13, 2001
QSAR of anticancer compounds. Bis(11-oxo-11H-indeno[1,2-b]quinoline-6-carboxamides), bis(phenazine-1-carboxamides), and bis(naphthalimides)S B Mekapati, W A Denny, A Kurup, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Bioorganic & Medicinal Chemistry|October 13, 2001
Comparative QSAR studies on bibenzimidazoles and terbenzimidazoles inhibiting topoisomerase IS B Mekapati, C Hansch
Bioorganic & Medicinal Chemistry|November 17, 2001
QSAR of the inhibition of angiogenesis by TNP-470 and ovalicin analogues: another example of an allosteric interactionS B Mekapati, C Hansch
Journal of Enzyme Inhibition|November 8, 2001
Quantitative structure-activity relationship of some HIV-1 protease inhibitors: a Fujita-Ban type analysisS B Mekapati, R Sivakumar, S P Gupta
Current Topics in Medicinal Chemistry|December 10, 2002
QSAR: then and nowC D Selassie, S B Mekapati, R P Verma
Bioorganic & Medicinal Chemistry|October 13, 2001
QSAR of anticancer compounds. Bis(11-oxo-11H-indeno[1,2-b]quinoline-6-carboxamides), bis(phenazine-1-carboxamides), and bis(naphthalimides)S B Mekapati, W A Denny, A Kurup, et al.
Pageof 1